–
Newron Pharmaceuticals SpA
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions EUR
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions EUR
FY21:
−12.4
FY22:
−13.3
FY23:
−11.6
FY24:
26.2
FY25:
−4.70
(positive)
Change from FY21 to FY25
millions EUR
FY21:
−11.8
FY22:
−13.3
FY23:
−11.8
FY24:
25.9
FY25:
−7.78
(positive)
Change from FY21 to FY25
millions EUR
FY21:
−14.9
FY22:
−17.5
FY23:
−16.2
FY24:
21.4
FY25:
−12.4
(positive)
Change from FY21 to FY25
millions EUR
FY21:
−14.9
FY22:
−17.5
FY23:
−16.2
FY24:
15.8
FY25:
−13.2
All amounts in millions EUR